A detailed history of Nuveen Asset Management, LLC transactions in Vericel Corp stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 128,270 shares of VCEL stock, worth $7.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
128,270
Previous 246,349 47.93%
Holding current value
$7.25 Million
Previous $11.3 Million 52.05%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$42.25 - $53.56 $4.99 Million - $6.32 Million
-118,079 Reduced 47.93%
128,270 $5.42 Million
Q2 2024

Aug 09, 2024

SELL
$41.71 - $52.9 $11.4 Million - $14.5 Million
-273,378 Reduced 52.6%
246,349 $11.3 Million
Q1 2024

May 13, 2024

SELL
$32.52 - $52.33 $2.83 Million - $4.56 Million
-87,177 Reduced 14.36%
519,727 $27 Million
Q4 2023

Feb 14, 2024

BUY
$30.85 - $37.09 $138,794 - $166,867
4,499 Added 0.75%
606,904 $21.6 Million
Q3 2023

Nov 14, 2023

BUY
$31.69 - $39.25 $6.5 Million - $8.05 Million
205,014 Added 51.59%
602,405 $20.2 Million
Q2 2023

Aug 14, 2023

BUY
$29.0 - $38.37 $7.88 Million - $10.4 Million
271,727 Added 216.23%
397,391 $14.9 Million
Q1 2023

May 15, 2023

SELL
$23.85 - $31.34 $595,129 - $782,027
-24,953 Reduced 16.57%
125,664 $3.68 Million
Q4 2022

Feb 14, 2023

SELL
$17.65 - $27.37 $695,921 - $1.08 Million
-39,429 Reduced 20.75%
150,617 $3.97 Million
Q3 2022

Nov 14, 2022

SELL
$22.62 - $32.54 $172,613 - $248,312
-7,631 Reduced 3.86%
190,046 $4.41 Million
Q2 2022

Aug 15, 2022

BUY
$22.88 - $39.45 $121,675 - $209,795
5,318 Added 2.76%
197,677 $4.98 Million
Q1 2022

May 16, 2022

SELL
$31.69 - $43.29 $238,720 - $326,103
-7,533 Reduced 3.77%
192,359 $6.35 Million
Q4 2021

Feb 14, 2022

SELL
$35.2 - $52.6 $4.48 Million - $6.7 Million
-127,400 Reduced 38.93%
199,892 $7.04 Million
Q3 2021

Nov 12, 2021

SELL
$46.35 - $59.75 $1.71 Million - $2.21 Million
-36,927 Reduced 10.14%
327,292 $16.9 Million
Q2 2021

Aug 16, 2021

SELL
$47.2 - $67.81 $1.82 Million - $2.61 Million
-38,561 Reduced 9.57%
364,219 $19.1 Million
Q1 2021

May 17, 2021

BUY
$30.93 - $59.48 $814,386 - $1.57 Million
26,330 Added 6.99%
402,780 $22.4 Million
Q4 2020

Feb 16, 2021

BUY
$18.53 - $31.5 $2.06 Million - $3.5 Million
111,045 Added 41.84%
376,450 $11.6 Million
Q3 2020

Nov 16, 2020

SELL
$14.68 - $19.12 $113,623 - $147,988
-7,740 Reduced 2.83%
265,405 $4.92 Million
Q2 2020

Aug 14, 2020

SELL
$8.5 - $15.82 $4.34 Million - $8.08 Million
-510,598 Reduced 65.15%
273,145 $3.78 Million
Q1 2020

May 14, 2020

BUY
$7.25 - $19.22 $179,930 - $477,001
24,818 Added 3.27%
783,743 $7.19 Million
Q4 2019

Feb 14, 2020

SELL
$13.77 - $19.2 $30,114 - $41,990
-2,187 Reduced 0.29%
758,925 $13.2 Million
Q3 2019

Nov 14, 2019

SELL
$14.93 - $19.83 $1.4 Million - $1.86 Million
-93,917 Reduced 10.98%
761,112 $11.5 Million
Q2 2019

Aug 15, 2019

BUY
$15.01 - $18.89 $12.8 Million - $16.2 Million
855,029 New
855,029 $16.2 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.